“Fludarabine-Based Conditioning For Marrow Transplantation From Unrelated Donors In Severe Aplastic Anemia: Early Results Of A Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events At Predefined Cyclophosphamide Dose Levels.”. Biol Blood Marrow Transplant 18 (7). Biol Blood Marrow Transplant: 1007-11. doi:10.1016/j.bbmt.2012.04.014.
. 2012. “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant To Hypomethylating Therapy Or Best Supportive Care In Patients Aged 50 To 75 With Intermediate-2 And High-Risk Myelodysplastic Syndrome: Blood And M”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1566-72. doi:10.1016/j.bbmt.2014.06.010.
. 2014. “Phase 3 Clinical Trial Of Steroids/mycophenolate Mofetil Vs Steroids/placebo As Therapy For Acute Gvhd: Bmt Ctn 0802.”. Blood 124 (22). Blood: 3221-7; quiz 3335. doi:10.1182/blood-2014-06-577023.
. 2014. “Tacrolimus/sirolimus Vs Tacrolimus/methotrexate As Gvhd Prophylaxis After Matched, Related Donor Allogeneic Hct.”. Blood 124 (8). Blood: 1372-7. doi:10.1182/blood-2014-04-567164.
. 2014.